Text Modules


Share

Program Content

Activities

  • HNSCC and COVID-19
    How We Are Managing Outpatient Head and Neck Cancer Care During the COVID-19 Pandemic
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 15, 2020

    Expires: July 14, 2021

  • Immunotherapy in HNSCC
    The Evolution of Immunotherapy in Head and Neck Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 08, 2020

    Expires: October 07, 2021

  • H&N Cancer: <i>NTRK</i> Fusions
    How I Manage Patients With NTRK Fusion–Positive Head and Neck Cancer
    Case Challenge
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 11, 2020

    Expires: November 10, 2021

  • Immunotherapy AEs in HNSCC
    Managing Immune-Related Adverse Events in Head and Neck Cancer
    Case Challenge
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 12, 2021

    Expires: February 11, 2022

Faculty

cover img faculity

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut

cover img faculity

Barbara Burtness, MD

Anthony N. Brady Professor of Medicine
Yale School of Medicine
Chief Translational Research Officer
Division Chief
Head and Neck/Sarcoma Oncology
Co-leader
Developmental Therapeutics Program
Director
Yale Head and Neck SPORE
Yale Cancer Center
Chair
ECOG-ACRIN Cancer Research Group
New Haven, Connecticut

cover img faculity

Cristina P. Rodriguez, MD

Associate Professor
Department of Medicine
University of Washington
Seattle, Washington

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.